Please use this identifier to cite or link to this item:
http://hdl.handle.net/2080/5709| Title: | Furamidine-Triggered Autophagy Mediates Anti-Mycobacterial Activity through Ca²⁺-Dependent SIRT1–AMPK–FOXO3a Signaling |
| Authors: | Patel, Salina Dandsena, Pramathesh Kumar Singh, Ramandeep Dhiman, Rohan |
| Keywords: | Tuberculosis Furamidine |
| Issue Date: | Jan-2026 |
| Citation: | International Conference on Turning the Tide: New Frontiers in TB Therapeutics, Vaccines and Diagnostics, University of Delhi South Campus & AIIMS, New Delhi, 19-21 January 2026 |
| Abstract: | Mycobacterium tuberculosis (M. tb), the causative agent of human tuberculosis (TB), continues to be a significant cause of mortality worldwide. The latest findings have highlighted autophagy as a host-defence mechanism that eradicates many invading bacteria, including M. tb. Thus, novel approaches like the stimulation of autophagy using various pharmaceutical drugs can be undertaken to deal with this noxious pathogen. The present study has been formulated to evaluate the anti-mycobacterial potential of Furamidine, a pharmaceutical drug from the LOPAC library. Initially, a non-cytotoxic concentration of Furamidine (10μM) was used to evaluate its effect on intracellular mycobacterial viability in dTHP-1 cells. Furamidine treatment compromised intracellular mycobacterial fitness compared to control cells. Autophagy, a well-known host defensive strategy was investigated as a possible contributor to reveal the mechanism of action. Multiparametric approaches were employed to study autophagic response that conclusively suggested the autophagy induction potential of Furamidine in dTHP-1 cells. Further, elevated LC3-II expression and increased autophagic vacuole accumulation in the presence of Baf-A1 demonstrated the positive regulation of autophagic flux upon Furamidine treatment. Pre-treatment of Wortmannin abrogated autophagy in treated cells, indicating the specificity of autophagy induction. Mechanistic investigations showed increased intracellular Ca2+ level expression, SIRT 1 and FOXO3a activation upon its treatment. Inhibition of Ca2+ level expression suppressed calcium-mediated-FOXO3a level in Furamidine-treated cells. Furthermore, the administration of various inhibitors hampered the Furamidine-induced autophagy, reducing intracellular mycobacteria clearance. These results conclude that Furamidine triggered the Ca2+/SIRT 1/FOXO3a pathway, causing less mycobacterial load in dTHP-1 cells. |
| Description: | Copyright belongs to the proceeding publisher. |
| URI: | http://hdl.handle.net/2080/5709 |
| Appears in Collections: | Conference Papers |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2026_ITBC_SPatel_Furamidine.pdf | Poster | 1.53 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
